FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for gabapentin submitted by Actavis Pharma, Inc. The action represents a supplemental regulatory action on an existing drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)